✦ LIBER ✦

Reply to a Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ Scribed by John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm M. DeCamp

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 113
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.23663

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Comparison of Survival and Disease-Spe

A Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ David H. Garfield; Wilbur A. Franklin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

T he recent article by Varlotto et al 1 raises issues that are prob- lematic in the recent and current bronchioloalveolar (BAC) literature. The third edition of the 1999 World Health Organization (WHO) consensus classification redefined BAC as an in situ tumor with a pure BAC growth pattern and with

A comparison of survival and disease-spe

A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer : Implications for adjuvant therapy

✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to assess whether disease‐specific survival (DSS) and overall survival (OS) differed among patients who had N1 and N2 bronchioloalveolar carcinoma (BAC) compared with patients who had non‐BAC nonsmall cell lung cancer (NSCLC). ## METHODS